Developer docs
API playgroundTry for free, no card

Search company profiles

Verogen

Full company profile

uuid0008wn6

Namestring
Verogen
Legal namestring
Verogen, Inc.
Websiteurl
verogen.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Verogen is a forensic genomics company founded in 2017 and headquartered in San Diego, California, that develops next-generation sequencing (NGS) workflows purpose-built for human identification and forensic casework. Its core platform consists of the MiSeq FGx Sequencing System — the only NDIS-approved NGS instrument for forensic genomics — paired with the Universal Analysis Software and a family of ForenSeq library preparation kits that target up to 230 STRs and SNPs in a single workflow, plus specialized kits for mitochondrial DNA whole-genome and control-region sequencing, NDIS-approved STR routine casework, ANAB-accredited forensic investigative genetic genealogy (FIGG), and externally visible characteristic / biogeographical ancestry estimation (ForenSeq Imagen). Verogen acquired the GEDmatch genetic genealogy database in December 2019; with more than 1.8 million profiles and a dedicated GEDmatch PRO portal, GEDmatch is the data substrate enabling ForenSeq Kintelligence–driven familial matching that has contributed to more than 500 cold-case resolutions since the 2018 Golden State Killer identification. The company monetizes through sales of NGS instruments, proprietary sequencing reagents and library prep kits (including reagent-rental and capital-lease bundles), Universal Analysis Software licenses (preinstalled on a dedicated server with no per-seat fees), annual support plans and service contracts, and professional services covering validation, training, relocation/qualification, and grant-writing assistance; enterprise field sales targets forensic laboratories and law enforcement agencies globally, supplemented by channel partners in indirect territories and, post-acquisition, by QIAGEN's commercial infrastructure. Verogen was acquired by QIAGEN N.V. in January 2023 for $150 million in cash and now operates as a wholly-owned subsidiary, with QIAGEN expecting approximately $20 million of sales from the Verogen portfolio in 2023 building on about $5 million of distribution-driven sales in 2022.

Short descriptiontext

Verogen develops next-generation sequencing instruments, library preparation kits, and analysis software for forensic laboratories and law enforcement agencies. It also stewards the GEDmatch genetic genealogy database. Verogen operates as a wholly-owned subsidiary of QIAGEN following its January 2023 acquisition.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
forensic genomics, next-generation sequencing, human identification, DNA sequencing kits, forensic DNA analysis
Industry4 codes
1Genomics & Next-Generation Sequencing (NGS) Services
CodeHLAGANAAPrimaryYes
2Molecular & Genetic Testing (PCR/NGS/qPCR)
CodeHLAGADAFPrimaryNo
3Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
CodeHLAAALADPrimaryNo
4Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
CodeHLAGAIAFPrimaryNo
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Forensic Genomics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1NGS Instrumentation Sales
TypeHardware Sales
Description

Sale of MiSeq FGx Sequencing System, Verogen PrepStation automation platform, and related hardware. Instruments can be purchased outright or through capital leases, asset-backed leases, or reagent rental programs.

verogen.com
2Sequencing Reagents and Consumables
TypeHardware Sales
Description

Sale of ForenSeq library preparation kits including DNA Signature Prep, MainstAY, Kintelligence, Imagen, and mtDNA kits, along with MiSeq FGx sequencing reagents. Reagent rental bundles instrument cost into per-test pricing.

verogen.com
3Support Plans and Service Contracts
TypeSubscription Recurring
Description

Annual and multi-year support plans covering software updates, field service response, preventative maintenance, and reagent compensation. Extended Support Plans provide priority service and on-site coverage for MiSeq FGx and UAS.

verogen.com
4Professional Services
TypeProfessional Services
Description

Grant writing specialists, validation services (Planned, Assisted, Full), training programs, relocation and qualification services provided to support NGS workflow implementation.

verogen.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1GEDmatch
Description

A genetic genealogy database that allows users to upload genetic profiles created by other genealogy sites to expand the search for familial links; contains more than 1.8 million genealogical profiles. Stewarded by Verogen.

verogen.com
+1 more record
Core offering1 text field

Verogen develops and sells a comprehensive next-generation sequencing (NGS) workflow for forensic human identification, consisting of ForenSeq library preparation kits, the NDIS-approved MiSeq FGx Sequencing System, Universal Analysis Software, and the GEDmatch/GEDmatch PRO genetic genealogy database. The portfolio targets forensic science laboratories and law enforcement agencies, enabling STR analysis, mtDNA sequencing, SNP-based phenotype/ancestry prediction, kinship analysis, and forensic investigative genetic genealogy (FIGG) for routine casework and cold case resolution.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • More than 500 cold cases solved using FIGG since 2018, including the Golden State Killer identification.
+4 more records
Product overview1 text field

Verogen offers a comprehensive next-generation sequencing (NGS) workflow for forensic genomics and human identification. The core platform consists of the MiSeq FGx Sequencing System (the first NDIS-approved NGS instrument for forensics) paired with Universal Analysis Software for data analysis. The portfolio includes multiple ForenSeq library preparation kits covering different forensic applications: DNA Signature Prep Kit targets up to 230 STRs and SNPs; MainstAY Product Line provides NDIS-approved STR markers for routine casework; Kintelligence Kit enables forensic investigative genetic genealogy (FIGG) for cold case resolution; Imagen Kit estimates appearance and biogeographical ancestry; and mtDNA kits sequence the mitochondrial genome or control region. Supporting the hardware are Verogen PrepStation for automated library prep and comprehensive service offerings including support plans, preventative maintenance, relocation, qualification, training, and validation services. The workflow is designed to go beyond traditional DNA profiles, enabling STR analysis, kinship estimation, phenotype prediction, and FIGG database matching through GEDmatch PRO.

Product and service16 records
1ForenSeq DNA Signature Prep Kit
CategoryLibrary Preparation Kit
Description

NGS library preparation kit targeting core autosomal and Y-STR loci accepted by global databases, plus advanced forensic intelligence markers for hair color, eye color, and biogeographical estimations. Evaluates up to 230 STRs and SNPs in a single workflow for forensic laboratories performing comprehensive human identification analysis.

2ForenSeq MainstAY Product Line
CategoryLibrary Preparation Kit
Description

NDIS-approved workflow generating 27 autosomal STR and 25 Y-STR markers compatible with regional database requirements for routine forensic casework, with approval for upload to the U.S. National DNA Index System (NDIS).

3ForenSeq Kintelligence Kit
CategoryLibrary Preparation Kit
Description

The only ANAB-accredited sequencing-based assay designed for forensic investigative genetic genealogy (FIGG). Generates SNP profiles that can be uploaded to GEDmatch PRO and FamilyTreeDNA for familial matching to solve violent crimes and identify missing persons.

4ForenSeq Imagen Kit
CategoryLibrary Preparation Kit
Description

Fully-validated appearance and biogeographical ancestry estimation tool using community-approved single nucleotide polymorphisms (SNPs). Generates phenotypic trait estimates including hair color, eye color, and biogeographical ancestry for investigative lead generation from crime-scene DNA samples.

5ForenSeq Enhanced PCR1 Buffer System
CategoryLibrary Preparation Reagent
Description

Enhanced PCR1 buffer system for improved performance when preparing ForenSeq libraries, designed to work with all ForenSeq kit workflows.

6ForenSeq mtDNA Whole Genome Kit
CategoryLibrary Preparation Kit
Description

Mitochondrial DNA sequencing kit for analyzing the entire mitochondrial genome, providing maximal variant detection and greater haplotype resolution for challenging forensic samples.

7ForenSeq mtDNA Control Region Kit
CategoryLibrary Preparation Kit
Description

Mitochondrial DNA sequencing kit targeting the highly mutated control region of mtDNA, maximizing variant detection in challenging forensic samples with degraded or compromised DNA.

8Verogen PrepStation
CategoryLaboratory Automation Instrument
Description

Cost-effective automation platform for forensic use with out-of-the-box scripts compatible with all ForenSeq kits. Designed to minimize human error and variance in library preparation to maximize case success.

9MiSeq FGx Sequencing System
CategoryNGS Sequencing Instrument
Description

The first and only NDIS-approved next-generation sequencing (NGS) instrument developed and validated specifically for forensic genomics. Provides both Forensic Genomics mode (FGx) and Research Use Only (RUO) mode for human identification applications.

10MiSeq FGx Sequencing Reagents
CategorySequencing Reagent
Description

Reagent kits and consumables required for sequencing on the MiSeq FGx Sequencing System, including the Reagent Micro Kit optimized for forensic genomics applications.

11Universal Analysis Software
CategoryData Analysis Software
Description

All-inclusive data analysis platform supporting all ForenSeq workflows (MainstAY, Kintelligence, DNA Signature Prep, mtDNA). Ships preinstalled on a dedicated Aegis server with no per-seat licenses required. Features application-specific modules, FASTQ generation, alignment, variant calling, and database-friendly report exports.

12Support Plans
CategoryService and Support
Description

Extended warranty and support coverage beyond first-year manufacturer warranty for MiSeq FGx System and Universal Analysis Software, including parts and labor coverage, reagent compensation, annual preventative maintenance, and software updates.

13Preventative Maintenance
CategoryService and Support
Description

Periodic maintenance service for MiSeq FGx System including pump syringe and air filter replacement, complete component inspection, optical and fluidics testing, and PhiX verification runs to maximize system performance.

14Relocation and Qualification
CategoryService and Support
Description

White Glove Service for relocating MiSeq FGx System, including packaging, transport, installation, and system verification. Qualification services include Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) for laboratory compliance.

15Training
CategoryService and Support
Description

On-site instruction for library prep, MiSeq FGx sequencing, and Universal Analysis Software. Includes three-day hands-on practical training with every instrument purchase, plus customized training for new personnel or advanced protocol review.

16Validation Services
CategoryProfessional Services
Description

Guided workflow validation aligned with SWGDAM guidelines. Service offerings include Planned (self-service roadmap), Assisted (expert data analysis support), and Full (white-glove validation, analysis, and reporting). Validates ForenSeq MainstAY, DNA Signature, and mtDNA workflows.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-08-15
Description

Multi-year strategic alliance to standardize forensic investigative genetic genealogy (FIGG) workflows. Gene by Gene supports DNA uploads generated from Verogen's ForenSeq Kintelligence kit to FamilyTreeDNA database, effectively doubling the number of profiles available for FIGG matching. Both organizations collaborate on developing superior algorithms and software for SNP profile generation and bioinformatics cost reduction. Customers can upload ForenSeq Kintelligence profiles to both GEDmatch PRO and FamilyTreeDNA databases. Gene by Gene also provides validated ForenSeq Kintelligence services and white-glove whole genome sequencing services for challenging forensic samples.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-10-19
Description

Verogen partnered with Cellmark Forensic Services to launch the UK's first ISO17025 accredited forensic next-generation sequencing service. Cellmark uses Verogen's MiSeq FGx Sequencing System and ForenSeq DNA Signature Prep Kit to provide advanced forensic DNA analysis services to UK law enforcement. The partnership followed Cellmark's extensive technology validation and consultation with the UK's Forensic Science Regulator, FINDS, UKAS, and other stakeholders. Cellmark has approximately 500 staff and delivers ISO17025 accredited forensic services from laboratories in Abingdon and Chorley, UK.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2021-06-01
Description

QIAGEN and Verogen announced a distribution agreement in June 2021 for the MiSeq FGx sequencer, NGS-based panels, and GEDmatch bioinformatics solutions. The partnership was elevated to a full acquisition in January 2023 when QIAGEN completed the purchase of Verogen for $150 million. QIAGEN gained exclusive distribution rights for the MiSeq FGx sequencer designed for forensics applications and full access to the GEDmatch database. QIAGEN already had a leading position in forensic sample collection and preparation kits, and the acquisition strengthened its leadership in the HID/forensics market segment.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

First accredited laboratory to use Forensic Genetic Genealogy for investigation; deploys Verogen's ForenSeq Kintelligence kit and VERSA 1100 automation for cold case resolution. Directly comparable as a forensic services lab operating the Verogen workflow.

TypeBroad incumbent
Description

Verogen's parent company and the acquirer. QIAGEN has a leading position in forensic sample collection and preparation kits and now sells Verogen's NGS workflow exclusively, making it the most directly comparable incumbent expanding into forensic genomics NGS.

TypeOthers
Description

Underlying sequencing platform provider for the MiSeq FGx System and supplier of NGS reagents to forensic labs globally. Comparable as the technology backbone Verogen's kits are built upon and a potential platform competitor if Illumina develops forensic-specific kits.

TypeEmerging player
Description

Forensic genomics laboratory that applies advanced sequencing and proprietary bioinformatics to help law enforcement identify remains and resolve cold cases. Comparable as an emerging forensic NGS service provider with overlapping FIGG capabilities.

TypeEmerging player
Description

Provider of forensic genetic genealogy, phenotyping, and DNA analysis services to law enforcement through the Parabon GeeGee platform. Comparable as an emerging forensic genomics player offering services that overlap with Verogen's Kintelligence and Imagen kits.

TypeBroad incumbent
Description

Major NGS instrument and reagent provider (Ion Torrent) with established human identification and forensic offerings. Comparable as a broad-incumbent sequencing vendor competing for forensic laboratory NGS budgets alongside Verogen's workflow.

TypeDirect peer
Description

Forensic DNA services provider offering traditional STR analysis, database uploads, and genetic genealogy services for law enforcement agencies. Comparable as a North American forensic laboratory service peer overlapping with Verogen's FIGG and routine casework offerings.

TypeDirect peer
Description

Established forensic DNA analysis supplier offering STR amplification kits, capillary electrophoresis workflows, and associated reagents for human identification. Directly comparable as a forensics-specialized life sciences reagent and workflow provider competing for the same laboratory budgets.

TypeDirect peer
Description

Strategic partner stewarding the FamilyTreeDNA genetic genealogy database, allied with Verogen to standardize FIGG workflows and offer whole genome sequencing services. Comparable as both a database steward and an adjacent forensic genomics service provider.

TypeDirect peer
Description

UK-based ISO17025-accredited forensic laboratory with approximately 500 staff that partnered with Verogen to launch the UK's first accredited forensic NGS service. Comparable as both an end-customer deploying Verogen's workflow and a peer forensic service provider.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Verogen

Forensic Genomicsverogen.com

Verogen develops next-generation sequencing instruments, library preparation kits, and analysis software for forensic laboratories and law enforcement agencies. It also stewards the GEDmatch genetic genealogy database. Verogen operates as a wholly-owned subsidiary of QIAGEN following its January 2023 acquisition.

What Verogen does

Verogen is a forensic genomics company founded in 2017 and headquartered in San Diego, California, that develops next-generation sequencing (NGS) workflows purpose-built for human identification and forensic casework. Its core platform consists of the MiSeq FGx Sequencing System — the only NDIS-approved NGS instrument for forensic genomics — paired with the Universal Analysis Software and a family of ForenSeq library preparation kits that target up to 230 STRs and SNPs in a single workflow, plus specialized kits for mitochondrial DNA whole-genome and control-region sequencing, NDIS-approved STR routine casework, ANAB-accredited forensic investigative genetic genealogy (FIGG), and externally visible characteristic / biogeographical ancestry estimation (ForenSeq Imagen). Verogen acquired the GEDmatch genetic genealogy database in December 2019; with more than 1.8 million profiles and a dedicated GEDmatch PRO portal, GEDmatch is the data substrate enabling ForenSeq Kintelligence–driven familial matching that has contributed to more than 500 cold-case resolutions since the 2018 Golden State Killer identification. The company monetizes through sales of NGS instruments, proprietary sequencing reagents and library prep kits (including reagent-rental and capital-lease bundles), Universal Analysis Software licenses (preinstalled on a dedicated server with no per-seat fees), annual support plans and service contracts, and professional services covering validation, training, relocation/qualification, and grant-writing assistance; enterprise field sales targets forensic laboratories and law enforcement agencies globally, supplemented by channel partners in indirect territories and, post-acquisition, by QIAGEN's commercial infrastructure. Verogen was acquired by QIAGEN N.V. in January 2023 for $150 million in cash and now operates as a wholly-owned subsidiary, with QIAGEN expecting approximately $20 million of sales from the Verogen portfolio in 2023 building on about $5 million of distribution-driven sales in 2022.

Verogen firmographics

Firmographics
Name
Verogen
Legal name
Verogen, Inc.
Website
https://verogen.com
Company type
Private
Founded year
2017
Operating status
Acquired
Headcount range
51–100 employees
Short description
Verogen develops next-generation sequencing instruments, library preparation kits, and analysis software for forensic laboratories and law enforcement agencies. It also stewards the GEDmatch genetic genealogy database. Verogen operates as a wholly-owned subsidiary of QIAGEN following its January 2023 acquisition.
Ownership category
akta.pro rank

Verogen industry classification

Industry
Product category
Forensic Genomics
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)
akta.pro secondary industries
Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

Keywords

  • Forensic genomics
  • Next-generation sequencing
  • Human identification
  • DNA sequencing kits
  • Forensic DNA analysis

Where Verogen is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Verogen business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. NGS Instrumentation Sales: Sale of MiSeq FGx Sequencing System, Verogen PrepStation automation platform, and related hardware. Instruments can be purchased outright or through capital leases, asset-backed leases, or reagent rental programs.
  2. Sequencing Reagents and Consumables: Sale of ForenSeq library preparation kits including DNA Signature Prep, MainstAY, Kintelligence, Imagen, and mtDNA kits, along with MiSeq FGx sequencing reagents. Reagent rental bundles instrument cost into per-test pricing.
  3. Support Plans and Service Contracts: Annual and multi-year support plans covering software updates, field service response, preventative maintenance, and reagent compensation. Extended Support Plans provide priority service and on-site coverage for MiSeq FGx and UAS.
  4. Professional Services: Grant writing specialists, validation services (Planned, Assisted, Full), training programs, relocation and qualification services provided to support NGS workflow implementation.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Verogen product offering

Product offering

Core offering

Verogen develops and sells a comprehensive next-generation sequencing (NGS) workflow for forensic human identification, consisting of ForenSeq library preparation kits, the NDIS-approved MiSeq FGx Sequencing System, Universal Analysis Software, and the GEDmatch/GEDmatch PRO genetic genealogy database. The portfolio targets forensic science laboratories and law enforcement agencies, enabling STR analysis, mtDNA sequencing, SNP-based phenotype/ancestry prediction, kinship analysis, and forensic investigative genetic genealogy (FIGG) for routine casework and cold case resolution.

Product overview

Verogen offers a comprehensive next-generation sequencing (NGS) workflow for forensic genomics and human identification. The core platform consists of the MiSeq FGx Sequencing System (the first NDIS-approved NGS instrument for forensics) paired with Universal Analysis Software for data analysis. The portfolio includes multiple ForenSeq library preparation kits covering different forensic applications: DNA Signature Prep Kit targets up to 230 STRs and SNPs; MainstAY Product Line provides NDIS-approved STR markers for routine casework; Kintelligence Kit enables forensic investigative genetic genealogy (FIGG) for cold case resolution; Imagen Kit estimates appearance and biogeographical ancestry; and mtDNA kits sequence the mitochondrial genome or control region. Supporting the hardware are Verogen PrepStation for automated library prep and comprehensive service offerings including support plans, preventative maintenance, relocation, qualification, training, and validation services. The workflow is designed to go beyond traditional DNA profiles, enabling STR analysis, kinship estimation, phenotype prediction, and FIGG database matching through GEDmatch PRO.

Differentiator

Problem solved

Functional benefit

Brands

  • GEDmatch: A genetic genealogy database that allows users to upload genetic profiles created by other genealogy sites to expand the search for familial links; contains more than 1.8 million genealogical profiles. Stewarded by Verogen.
  • GEDmatch PRO

Products and services

  • ForenSeq DNA Signature Prep Kit NGS library preparation kit targeting core autosomal and Y-STR loci accepted by global databases, plus advanced forensic intelligence markers for hair color, eye color, and biogeographical estimations. Evaluates up to 230 STRs and SNPs in a single workflow for forensic laboratories performing comprehensive human identification analysis.
  • ForenSeq MainstAY Product Line NDIS-approved workflow generating 27 autosomal STR and 25 Y-STR markers compatible with regional database requirements for routine forensic casework, with approval for upload to the U.S. National DNA Index System (NDIS).
  • ForenSeq Kintelligence Kit The only ANAB-accredited sequencing-based assay designed for forensic investigative genetic genealogy (FIGG). Generates SNP profiles that can be uploaded to GEDmatch PRO and FamilyTreeDNA for familial matching to solve violent crimes and identify missing persons.
  • ForenSeq Imagen Kit Fully-validated appearance and biogeographical ancestry estimation tool using community-approved single nucleotide polymorphisms (SNPs). Generates phenotypic trait estimates including hair color, eye color, and biogeographical ancestry for investigative lead generation from crime-scene DNA samples.
  • ForenSeq Enhanced PCR1 Buffer System Enhanced PCR1 buffer system for improved performance when preparing ForenSeq libraries, designed to work with all ForenSeq kit workflows.
  • ForenSeq mtDNA Whole Genome Kit Mitochondrial DNA sequencing kit for analyzing the entire mitochondrial genome, providing maximal variant detection and greater haplotype resolution for challenging forensic samples.
  • ForenSeq mtDNA Control Region Kit Mitochondrial DNA sequencing kit targeting the highly mutated control region of mtDNA, maximizing variant detection in challenging forensic samples with degraded or compromised DNA.
  • Verogen PrepStation Cost-effective automation platform for forensic use with out-of-the-box scripts compatible with all ForenSeq kits. Designed to minimize human error and variance in library preparation to maximize case success.
  • MiSeq FGx Sequencing System The first and only NDIS-approved next-generation sequencing (NGS) instrument developed and validated specifically for forensic genomics. Provides both Forensic Genomics mode (FGx) and Research Use Only (RUO) mode for human identification applications.
  • MiSeq FGx Sequencing Reagents Reagent kits and consumables required for sequencing on the MiSeq FGx Sequencing System, including the Reagent Micro Kit optimized for forensic genomics applications.
  • Universal Analysis Software All-inclusive data analysis platform supporting all ForenSeq workflows (MainstAY, Kintelligence, DNA Signature Prep, mtDNA). Ships preinstalled on a dedicated Aegis server with no per-seat licenses required. Features application-specific modules, FASTQ generation, alignment, variant calling, and database-friendly report exports.
  • Support Plans Extended warranty and support coverage beyond first-year manufacturer warranty for MiSeq FGx System and Universal Analysis Software, including parts and labor coverage, reagent compensation, annual preventative maintenance, and software updates.
  • Preventative Maintenance Periodic maintenance service for MiSeq FGx System including pump syringe and air filter replacement, complete component inspection, optical and fluidics testing, and PhiX verification runs to maximize system performance.
  • Relocation and Qualification White Glove Service for relocating MiSeq FGx System, including packaging, transport, installation, and system verification. Qualification services include Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) for laboratory compliance.
  • Training On-site instruction for library prep, MiSeq FGx sequencing, and Universal Analysis Software. Includes three-day hands-on practical training with every instrument purchase, plus customized training for new personnel or advanced protocol review.
  • Validation Services Guided workflow validation aligned with SWGDAM guidelines. Service offerings include Planned (self-service roadmap), Assisted (expert data analysis support), and Full (white-glove validation, analysis, and reporting). Validates ForenSeq MainstAY, DNA Signature, and mtDNA workflows.

Quantifiable outcome

  • More than 500 cold cases solved using FIGG since 2018, including the Golden State Killer identification.
  • +4 more outcomes

Companies that use Verogen

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Verogen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability1 record

Feature8 records

Verogen partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and flagship.

  • Gene by Gene (FamilyTreeDNA)coreStrategic or Co-development Partner · 15 August 2022Multi-year strategic alliance to standardize forensic investigative genetic genealogy (FIGG) workflows. Gene by Gene supports DNA uploads generated from Verogen's ForenSeq Kintelligence kit to FamilyTreeDNA database, effectively doubling the number of profiles available for FIGG matching. Both organizations collaborate on developing superior algorithms and software for SNP profile generation and bioinformatics cost reduction. Customers can upload ForenSeq Kintelligence profiles to both GEDmatch PRO and FamilyTreeDNA databases. Gene by Gene also provides validated ForenSeq Kintelligence services and white-glove whole genome sequencing services for challenging forensic samples.
  • Cellmark Forensic ServicescoreStrategic or Co-development Partner · 19 October 2021Verogen partnered with Cellmark Forensic Services to launch the UK's first ISO17025 accredited forensic next-generation sequencing service. Cellmark uses Verogen's MiSeq FGx Sequencing System and ForenSeq DNA Signature Prep Kit to provide advanced forensic DNA analysis services to UK law enforcement. The partnership followed Cellmark's extensive technology validation and consultation with the UK's Forensic Science Regulator, FINDS, UKAS, and other stakeholders. Cellmark has approximately 500 staff and delivers ISO17025 accredited forensic services from laboratories in Abingdon and Chorley, UK.
  • QIAGENflagshipStrategic or Co-development Partner · 1 June 2021QIAGEN and Verogen announced a distribution agreement in June 2021 for the MiSeq FGx sequencer, NGS-based panels, and GEDmatch bioinformatics solutions. The partnership was elevated to a full acquisition in January 2023 when QIAGEN completed the purchase of Verogen for $150 million. QIAGEN gained exclusive distribution rights for the MiSeq FGx sequencer designed for forensics applications and full access to the GEDmatch database. QIAGEN already had a leading position in forensic sample collection and preparation kits, and the acquisition strengthened its leadership in the HID/forensics market segment.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Verogen competitors and assessment

Company assessment

Direct peers

  • DNA Labs International: First accredited laboratory to use Forensic Genetic Genealogy for investigation; deploys Verogen's ForenSeq Kintelligence kit and VERSA 1100 automation for cold case resolution. Directly comparable as a forensic services lab operating the Verogen workflow.
  • Bode Technology: Forensic DNA services provider offering traditional STR analysis, database uploads, and genetic genealogy services for law enforcement agencies. Comparable as a North American forensic laboratory service peer overlapping with Verogen's FIGG and routine casework offerings.
  • Promega Corporation: Established forensic DNA analysis supplier offering STR amplification kits, capillary electrophoresis workflows, and associated reagents for human identification. Directly comparable as a forensics-specialized life sciences reagent and workflow provider competing for the same laboratory budgets.
  • Gene by Gene / FamilyTreeDNA: Strategic partner stewarding the FamilyTreeDNA genetic genealogy database, allied with Verogen to standardize FIGG workflows and offer whole genome sequencing services. Comparable as both a database steward and an adjacent forensic genomics service provider.
  • Cellmark Forensic Services: UK-based ISO17025-accredited forensic laboratory with approximately 500 staff that partnered with Verogen to launch the UK's first accredited forensic NGS service. Comparable as both an end-customer deploying Verogen's workflow and a peer forensic service provider.

Broad incumbents

  • QIAGEN: Verogen's parent company and the acquirer. QIAGEN has a leading position in forensic sample collection and preparation kits and now sells Verogen's NGS workflow exclusively, making it the most directly comparable incumbent expanding into forensic genomics NGS.
  • Thermo Fisher Scientific: Major NGS instrument and reagent provider (Ion Torrent) with established human identification and forensic offerings. Comparable as a broad-incumbent sequencing vendor competing for forensic laboratory NGS budgets alongside Verogen's workflow.

Others

  • Illumina: Underlying sequencing platform provider for the MiSeq FGx System and supplier of NGS reagents to forensic labs globally. Comparable as the technology backbone Verogen's kits are built upon and a potential platform competitor if Illumina develops forensic-specific kits.

Emerging players

  • Othram: Forensic genomics laboratory that applies advanced sequencing and proprietary bioinformatics to help law enforcement identify remains and resolve cold cases. Comparable as an emerging forensic NGS service provider with overlapping FIGG capabilities.
  • Parabon NanoLabs: Provider of forensic genetic genealogy, phenotyping, and DNA analysis services to law enforcement through the Parabon GeeGee platform. Comparable as an emerging forensic genomics player offering services that overlap with Verogen's Kintelligence and Imagen kits.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Verogen social profiles

Digital presence

Verogen compliance and trust

Trust signal

Compliance2 records

Verogen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Verogen leadership team

Management profile

Number of profiles

Profiles4 records

Verogen funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Verogen M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Verogen

What does Verogen do?

Verogen develops and sells a comprehensive next-generation sequencing (NGS) workflow for forensic human identification, consisting of ForenSeq library preparation kits, the NDIS-approved MiSeq FGx Sequencing System, Universal Analysis Software, and the GEDmatch/GEDmatch PRO genetic genealogy database. The portfolio targets forensic science laboratories and law enforcement agencies, enabling STR analysis, mtDNA sequencing, SNP-based phenotype/ancestry prediction, kinship analysis, and forensic investigative genetic genealogy (FIGG) for routine casework and cold case resolution.

Is Verogen a public or private company?

Verogen is a private company. It is classified as corporate owned and is currently acquired.

When was Verogen founded?

Verogen was founded in 2017. It employs 51 to 100 people.

Where is Verogen based?

Verogen is headquartered in San Diego, United States, in the North America region.

How does Verogen make money?

Four revenue lines are on record. NGS Instrumentation Sales are the primary driver. The others are sequencing Reagents and Consumables, support Plans and Service Contracts and professional Services.

Who are Verogen's main competitors?

Direct peers on record are DNA Labs International, Bode Technology, Promega Corporation, Gene by Gene / FamilyTreeDNA and Cellmark Forensic Services. Broad incumbents are QIAGEN and Thermo Fisher Scientific. Illumina is listed as an others. Emerging players are Othram and Parabon NanoLabs.

Does Verogen have an API?

No public API is recorded for Verogen.

What industry is Verogen in?

Verogen's product category is Forensic Genomics. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 541714 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comKey Factors and Emerging Trends Shaping the Future of the Next-Generation Sequencing Data Analysis MarketThe next-generation sequencing data analysis market is projected to reach $3.93 billion by 2030, growing at a compound annual growth rate of 21.5%, driven by AI adoption in variant interpretation, personalized medicine, and increased demand for real-time genomic data. In January 2023, Germany-based QIAGEN acquired US-based Verogen to expand its forensic genomics capabilities, gaining access to the GEDmatch database and MiSeq FGx Sequencing System. South Korea-based Vieworks launched the LUCEON 510 digital pathology slide scanner in September 2024 at the European Congress of Pathology.openPR.comOverview of Segmentation, Market Dynamics, and Competitive Landscape in the Next Generation Sequencing (NGS) Sample Preparation MarketThe Next Generation Sequencing (NGS) sample preparation market is projected to grow to $7.1 billion by 2030, with a compound annual growth rate of 14.5%, driven by integration in routine diagnostics, automation of sample preparation workflows, and increased oncology and rare disease sequencing. QIAGEN N.V. acquired Verogen for $150 million in January 2023 to strengthen its forensic and genetic testing portfolio, while Sartorius AG from Germany launched the Vivaflow SU tangential flow filtration cassette in September 2024 as part of sustainable laboratory equipment trends. The market report covers segmentation across products, workflow stages, technologies, applications, and end users, with key players including Illumina, Thermo Fisher Scientific, Roche, and other biotech firms.openPR.comMarket Trend Analysis: The Impact of Recent Advancements on the DNA Test Kits MarketThe DNA test kits market is projected to grow to $5.52 billion by 2030, representing a compound annual growth rate of 16.7%, driven by personalized wellness adoption, digital health platforms, and preventive healthcare focus. In January 2023, Germany-based biotechnology firm QIAGEN N.V. acquired Verogen Inc., a US-based forensic DNA test kit company, for $150 million to strengthen its position in human identification and forensic science. The article also details market segmentation by sample type, application, and end user, and lists numerous companies operating in the DNA test kits sector.openPR.comTop Players and Competitive Dynamics in the DNA Testing MarketThe DNA testing market is projected to grow to $32.71 billion by 2030, representing a compound annual growth rate of 9.9%, driven by precision medicine integration, AI-powered genetic interpretation, population screening expansion, and clinical genomics growth. In January 2023, QIAGEN N.V., a biotechnology firm based in the Netherlands, acquired Verogen Inc., a U.S.-based forensic genomics company, for $150 million to strengthen QIAGEN's leadership in human identification and forensic markets. The article provides an industry overview including market drivers, trends, segmentation, and a comprehensive list of major players in the DNA testing sector.openPR.comLeading Companies Advancing Innovation and Growth in the Clinical Next-Generation Sequencing (NGS) Data Analysis MarketThe global clinical NGS data analysis market is projected to reach $9.4 billion by 2030, growing at a 17.2% CAGR, driven by AI integration in genomic interpretation, personalized medicine demand, and clinical genomics applications in oncology and rare diseases. QIAGEN NV acquired US-based Verogen for $150 million in January 2023 to strengthen its forensic genomics portfolio, exemplifying market consolidation activity. The Asia-Pacific region is expected to experience the fastest growth, while North America currently holds the largest market share as of 2024.openPR.comMarket Structure, Key Trends, and Top Player Analysis in the Sequencing Consumables IndustryThe sequencing consumables market is projected to reach $36.6 billion by 2030, growing at a compound annual growth rate of 23.6%, driven by personalized medicine demand, infectious disease genomics expansion, and third-generation sequencing adoption. In January 2023, Germany-based QIAGEN N.V. acquired US firm Verogen for an undisclosed sum to strengthen its human identification and forensic applications portfolio through next-generation sequencing technologies. In March 2023, Illumina Inc. launched the Illumina Complete Long Read Prep - Human, a long-read whole-genome sequencing assay compatible with its NovaSeq sequencing systems.IlluminaNGS solutions for forensic applicationsIllumina and Telegraph Hill Partners launched Verogen, an independent company granted exclusive rights to provide Illumina's forensic sequencing technology and commercialize the MiSeq FGx Forensic Genomics System globally. The article highlights that NGS technology offers higher resolution and efficiency for forensic DNA analysis compared to traditional methods, enabling better results from compromised samples. Othram is cited as a user of this technology, specifically utilizing the NovaSeq System to solve cold cases.PR NewswirePharmacogenomics Market Worth $5.8 Billion | MarketsandMarkets™MarketsandMarkets projects the global pharmacogenomics market to grow from $3.5 billion in 2023 to $5.8 billion by 2028, representing a compound annual growth rate of 10.6%. Key growth drivers include the rising incidence of cancer, increasing collaborations between industry players and research institutes, and a growing focus on personalized medicine. North America accounted for the largest regional market share in 2022, with notable recent transactions including QIAGEN's acquisition of Verogen and Integrated DNA Technologies' purchase of Archer NGS research assays from Invitae.FinSMEsQiagen Completes Acquisition of VerogenQIAGEN acquired Verogen, a DNA-based human identification and forensic company, for $150 million in cash. The deal is expected to generate about $20 million in sales in 2023, with a dilutive impact of about $0.03 per share on adjusted EPS.BenzingaQIAGEN Acquires Verogen Strengthening Its Position In Human ID / Forensics - Qiagen (NYSE:QGEN)QIAGEN NV has acquired Verogen, a privately held forensic genomics company based in San Diego, for $150 million, with the transaction expected to generate approximately $20 million in sales in 2023. The deal gives QIAGEN exclusive distribution rights for the MiSeq FGx Sequencing System and full access to Verogen's GEDmatch genealogy database containing over 1.8 million profiles. The acquisition is expected to be dilutive to 2023 adjusted EPS by approximately $0.03 per share but neutral to adjusted EPS in 2024.